Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
Lawrence Thompson Bowles, MD, PhD, who served as the dean of George Washington University (GW) School of Medicine and Health Sciences (SMHS) from 1976 until 1988, and then as vice president for medical affairs and executive dean of the GW Medical Center until 1992, passed away Sept. 15, just days…
Nofar Erlichman, PhD, a postdoctoral associate at the George Washington University School of Medicine and Health Sciences, was awarded a postdoctoral fellowship from the American Cancer Society for her project, “Adipocyte PD-L1 mediates the promotion of mammary tumor growth by the sympathetic…
The GW School of Medicine and Health Sciences welcomed the 2026 cohort of the Integrated Biomedical Sciences (IBS) PhD Program. Over the program’s 30-year history, GW has graduated 340 PhD who have gone on to careers across the biomedical sciences.
